StockVS

Owlet, Inc. (OWLT) Stock Analysis

Healthcare

Owlet, Inc.

$5.73

$-0.06 (-1.04%)

Last Updated: May 26, 2026

Price History

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Company Overview

Owlet, Inc. operates within the healthcare sector, specifically focusing on the medical devices industry where it delivers digital parenting solutions to parents in the United States, the United Kingdom, and international markets. The company's core offerings include a digital parenting platform that supplies real-time data and insights, alongside wearable infant health monitors such as the Dream Sock. In terms of scale, Owlet, Inc. maintains a market capitalization of $143.90M with an annual revenue of $105.71M and an workforce of 108 employees. These financial figures indicate that the company is a relatively small-cap entity generating significant revenue relative to its size, suggesting a business model that relies heavily on high-volume consumer adoption rather than massive institutional infrastructure. The market cap reflects investor sentiment regarding the company's growth potential in the digital health space, while the revenue figure demonstrates its ability to monetize its product suite despite operating in a niche segment of the broader medical device industry.

Financial Health

The company reported revenue of $105.71M over the trailing twelve months, yet this generated a net income of $-41,855,000 and an EBITDA of $-8,059,000. The substantial gap between the positive revenue figure and the deeply negative net income reveals a cost structure where operating expenses and loss-making investments significantly outweigh gross profits before interest and taxes. Free cash flow stands at $-12,104,375, which indicates that the company is currently burning cash and lacks the immediate financial flexibility to fund operations without external capital injections or debt financing. The margins further illustrate this financial pressure, with a gross margin of 50.6% showing efficient production, but an operating margin of -18.4% and a profit margin of -37.5% highlighting severe underperformance in converting revenue into bottom-line profit. On the balance sheet, the company holds $35.46M in cash against $13.12M in debt, resulting in a debt-to-equity ratio of 42.26, which suggests a leveraged position where equity capital is used to finance a relatively small debt load. However, the current ratio of 1.85 indicates that the company possesses sufficient short-term assets to cover its short-term liabilities, providing a buffer against immediate liquidity crises. Return on Equity is recorded at -802.5% and Return on Assets at -7.6%, metrics that reveal management has not yet generated positive returns on the capital invested or the assets deployed, pointing to significant challenges in operational efficiency or strategic execution.

Valuation Assessment

Valuation multiples for Owlet, Inc. present a mixed picture, with a trailing P/E ratio listed as N/A due to negative earnings, while the forward P/E stands at 56.78. The disparity between a non-existent trailing P/E and a high forward P/E of 56.78 implies that the market is pricing in substantial future earnings growth expectations to justify the current stock price. The price-to-book ratio is 7.23, indicating that the market is valuing the company at a significant premium over its net asset book value, suggesting investors are willing to pay more for the company's future prospects than its tangible assets warrant. Alternative metrics provide further context, with a price-to-sales ratio of 1.36 and an EV/EBITDA of -16.57, which suggests the company is valued based on revenue generation rather than current profitability or earnings power. Regarding price levels, the stock has traded between a 52-week high of $16.94 and a 52-week low of $2.75. Without a specific current price provided in the available facts to calculate an exact percentage, the stock's position within this wide range of $14.19 indicates high volatility and potential for significant price swings relative to its recent trading history. The beta value is 1.74, which means the stock exhibits high price volatility and is expected to move with much greater intensity than the broader market index.

Growth & Income

Owlet, Inc. demonstrated a revenue growth rate of 29.6% year-over-year, whereas earnings growth is listed as N/A due to the company's current losses. The fact that earnings growth is not applicable while revenue grows indicates that the company is expanding its top line but has not yet achieved the profitability required to generate earnings growth comparable to its sales expansion. As a non-dividend payer with a dividend yield of N/A and a payout ratio of 0.0%, the company does not distribute cash to shareholders, implying that any available cash flow is being reinvested into the business or used to service debt rather than being paid out. This reinvestment strategy is typical for growth-stage companies that prioritize funding research, development, and market expansion over returning capital to investors. The overall growth and income profile for Owlet, Inc. is characterized by strong revenue expansion in the digital health sector but a lack of current profitability or dividend income, positioning the asset as a high-risk, high-potential growth play rather than an income-generating investment.

Peer Comparison

Owlet, Inc. (OWLT) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Owlet, Inc. OWLT $167.92M N/A
Abbott Laboratories ABT $150.96B 24.3
Stryker Corporation SYK $119.99B 36.2
Medtronic plc MDT $99.63B 21.7

The Medical Devices industry average P/E ratio is 60.2x. Owlet, Inc. trades at a P/E of N/A.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About Owlet, Inc.

Owlet, Inc. provides digital parenting solutions in the United States, the United Kingdom, and internationally. The company offers a digital parenting platform that provides real-time data and insights to parents. It also provides sock monitors, including Dream Sock, a wearable infant health monitor equipped with pulse oximetry technology that tracks vital signs, such as pulse rate, activity, oxygen level, and sleep patterns; BabySat, which is intended for infants with conditions, including respiratory syncytial virus, pneumonia, bronchitis, croup, and other diagnoses; and Dream Sight, an audio and video monitor that enables parents to monitor their child. In addition, the company offers Dream Duo, which integrates Dream Sock and Dream Sight to create a connected health and safety system; Owlet360, a subscription service that provides personalized understanding of the babies' development, health, and sleep trends; and accessories, such as fabric accessory socks and the Owlet Sock Travel Case. The company was founded in 2012 and is headquartered in Lehi, Utah.

Visit website →

Key Statistics

Market Cap
$167.92M
P/E Ratio
N/A
52-Week High
$16.94
52-Week Low
$4.19
Avg Volume
320.62K
Beta
1.83

Data provided by Yahoo Finance via yfinance. Updated daily.

Company Info

Exchange
NYSE
Country
United States
Employees
108